The Cardiac Rhythm Management (CRM) portfolio comprises of implantable pacemakers and defibrillators, leads, accessories and external devices to treat and manage arrhythmia-related diseases. These specifically designed implantable devices treat patients with either too slow a heart rhythm (bradycardia) or too fast a rhythm (tachycardia).

Our broad range of products work to restore blood flow to vessels of the heart (coronary) and body (peripheral) that are narrowed or blocked.  We produce a full range of stent systems, balloon catheters and guide wires for patients with coronary and peripheral artery disease.

BIOTRONIK is a true innovator in the field, having introduced Pulsar, the world's first 4F-compatible stent for treating long lesions, in 2009 and Orsiro, the industry's first hybrid drug-eluting stent, in 2011.

BIOTRONIK has an unsurpassed legacy of providing quality therapy solutions. We cultivate expertise in understanding the challenges electrophysiologists face so that we can provide state-of-the-art technology with precise performance and highly reliable results.